AstraZeneca COVID-19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series.

Amira SiddigKhabab Abbasher Hussien Mohamed AhmedMazin S Hassan HarounAbdallah M AbdallahMohamed MalekaldarAl Hussien AbbasherMohammed AbbasherAbubaker Alsedig AbbasherAbbasher Hussien

Published in: Clinical case reports (2022)

One of the most prevalent neurological impairments is cerebrovascular accident (CVA). Ischemic stroke and CVST have been linked to the AstraZeneca COVID-19 vaccine. Three Sudanese patients developed these diseases after receiving the AstraZeneca COVID-19 vaccine, indicating a relationship between the AstraZeneca COVID-19 vaccine and these conditions.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
chronic kidney disease
newly diagnosed
pulmonary embolism
prognostic factors
peritoneal dialysis